PubRank

Bernard Payrastre

Author PubWeight™ 89.14‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor. Cell 2003 3.36
2 Osh4p exchanges sterols for phosphatidylinositol 4-phosphate between lipid bilayers. J Cell Biol 2011 2.22
3 Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation. Nat Chem Biol 2008 2.12
4 Antileukemic activity of rapamycin in acute myeloid leukemia. Blood 2004 2.03
5 Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S.flexneri effector IpgD reorganizes host cell morphology. EMBO J 2002 1.94
6 The new tyrosine-kinase inhibitor and anticancer drug dasatinib reversibly affects platelet activation in vitro and in vivo. Blood 2009 1.84
7 Origin, originality, functions, subversions and molecular signalling of macropinocytosis. Int J Med Microbiol 2002 1.72
8 The phosphoinositide kinase PIKfyve/Fab1p regulates terminal lysosome maturation in Caenorhabditis elegans. Mol Biol Cell 2006 1.66
9 Production of phosphatidylinositol 5-phosphate by the phosphoinositide 3-phosphatase myotubularin in mammalian cells. J Biol Chem 2003 1.58
10 Proteasome inhibitor-induced apoptosis in acute myeloid leukemia: a correlation with the proteasome status. Leuk Res 2009 1.52
11 PtdIns5P activates the host cell PI3-kinase/Akt pathway during Shigella flexneri infection. EMBO J 2006 1.45
12 A critical role for Lyn in acute myeloid leukemia. Blood 2007 1.40
13 Expression of focal adhesion kinase in acute myeloid leukemia is associated with enhanced blast migration, increased cellularity, and poor prognosis. Cancer Res 2004 1.38
14 The phosphatidylinositol (PI)-5-phosphate 4-kinase type II enzyme controls insulin signaling by regulating PI-3,4,5-trisphosphate degradation. Proc Natl Acad Sci U S A 2003 1.37
15 A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy. Hum Mol Genet 2006 1.33
16 Polo-like kinase 1 is overexpressed in acute myeloid leukemia and its inhibition preferentially targets the proliferation of leukemic cells. Blood 2009 1.31
17 Phosphoinositide signaling disorders in human diseases. FEBS Lett 2003 1.29
18 Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60c-src to mediate its mitogenicity. Blood 2003 1.22
19 Myotubularin controls desmin intermediate filament architecture and mitochondrial dynamics in human and mouse skeletal muscle. J Clin Invest 2010 1.21
20 mTOR, a new therapeutic target in acute myeloid leukemia. Cell Cycle 2005 1.19
21 Type II phosphatidylinositol 4-kinases promote Listeria monocytogenes entry into target cells. Cell Microbiol 2007 1.18
22 Phosphatidylinositol 3-phosphate, an essential lipid in Plasmodium, localizes to the food vacuole membrane and the apicoplast. Eukaryot Cell 2010 1.16
23 Functional redundancy in the myotubularin family. Biochem Biophys Res Commun 2002 1.15
24 Expression of myotubularin by an adenoviral vector demonstrates its function as a phosphatidylinositol 3-phosphate [PtdIns(3)P] phosphatase in muscle cell lines: involvement of PtdIns(3)P in insulin-stimulated glucose transport. Mol Endocrinol 2003 1.15
25 A FRET analysis to unravel the role of cholesterol in Rac1 and PI 3-kinase activation in the InlB/Met signalling pathway. Cell Microbiol 2006 1.13
26 Deletion of the p110beta isoform of phosphoinositide 3-kinase in platelets reveals its central role in Akt activation and thrombus formation in vitro and in vivo. Blood 2010 1.12
27 Alteration of epithelial structure and function associated with PtdIns(4,5)P2 degradation by a bacterial phosphatase. J Gen Physiol 2007 1.07
28 Molecular networks linked by Moesin drive remodeling of the cell cortex during mitosis. J Cell Biol 2011 1.07
29 Cutting edge: Dok-1 and Dok-2 adaptor molecules are regulated by phosphatidylinositol 5-phosphate production in T cells. J Immunol 2009 1.06
30 Integrin-dependent interaction of lipid rafts with the actin cytoskeleton in activated human platelets. J Cell Sci 2005 1.05
31 Deficiency of Src homology 2 domain-containing inositol 5-phosphatase 1 affects platelet responses and thrombus growth. J Clin Invest 2007 1.04
32 Phosphoinositide phosphatases in a network of signalling reactions. Pflugers Arch 2007 1.03
33 Shigella flexneri infection generates the lipid PI5P to alter endocytosis and prevent termination of EGFR signaling. Sci Signal 2011 1.02
34 A "liaison dangereuse" between AUF1/hnRNPD and the oncogenic tyrosine kinase NPM-ALK. Blood 2006 1.02
35 Genetic interaction between MTMR2 and FIG4 phospholipid phosphatases involved in Charcot-Marie-Tooth neuropathies. PLoS Genet 2011 1.01
36 The human tumour suppressor PTEN regulates longevity and dauer formation in Caenorhabditis elegans. Oncogene 2005 1.00
37 Roles of the C-terminal tyrosine residues of LAT in GPVI-induced platelet activation: insights into the mechanism of PLC gamma 2 activation. Blood 2007 1.00
38 Phosphatidylinositol 3-monophosphate is involved in toxoplasma apicoplast biogenesis. PLoS Pathog 2011 0.99
39 Myotubularin and PtdIns3P remodel the sarcoplasmic reticulum in muscle in vivo. J Cell Sci 2013 0.97
40 PtdIns5P: a little phosphoinositide with big functions? Biochem Soc Symp 2007 0.97
41 Matrix metalloproteinase-9 is upregulated in nucleophosmin-anaplastic lymphoma kinase-positive anaplastic lymphomas and activated at the cell surface by the chaperone heat shock protein 90 to promote cell invasion. Cancer Res 2010 0.96
42 A New alpha5beta1 integrin-dependent survival pathway through GSK3beta activation in leukemic cells. PLoS One 2010 0.95
43 Emerging roles of phosphatidylinositol monophosphates in cellular signaling and trafficking. Adv Enzyme Regul 2005 0.94
44 Phosphatase-dead myotubularin ameliorates X-linked centronuclear myopathy phenotypes in mice. PLoS Genet 2012 0.93
45 Focal adhesion kinase splice variants maintain primitive acute myeloid leukemia cells through altered Wnt signaling. Stem Cells 2012 0.93
46 Regulation and roles of PI3Kβ, a major actor in platelet signaling and functions. Adv Enzyme Regul 2010 0.90
47 Phosphatidylinositol 5-phosphate: a nuclear stress lipid and a tuner of membranes and cytoskeleton dynamics. Bioessays 2013 0.90
48 A functional link between polo-like kinase 1 and the mammalian target-of-rapamycin pathway? Cell Cycle 2010 0.90
49 The phosphoinositide phosphatase MTM-1 regulates apoptotic cell corpse clearance through CED-5-CED-12 in C. elegans. Development 2011 0.90
50 PtdIns5P protects Akt from dephosphorylation through PP2A inhibition. Biochem Biophys Res Commun 2009 0.90
51 Rac1 inactivation by lethal toxin from Clostridium sordellii modifies focal adhesions upstream of actin depolymerization. Cell Microbiol 2009 0.89
52 SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels. Biochem J 2003 0.89
53 Lipid rafts are critical membrane domains in blood platelet activation processes. Biochim Biophys Acta 2003 0.88
54 Mechanical constraint imposed on plasma membrane through transverse phospholipid imbalance induces reversible actin polymerization via phosphoinositide 3-kinase activation. J Cell Sci 2003 0.88
55 Regulation of the DH-PH tandem of guanine nucleotide exchange factor for Rho GTPases by phosphoinositides. Adv Biol Regul 2012 0.87
56 Assessment of somatic mutations in phosphatidylinositol 3-kinase gene in human lymphoma and acute leukaemia. Br J Haematol 2005 0.87
57 SHIP2 overexpression strongly reduces the proliferation rate of K562 erythroleukemia cell line. Biochem Biophys Res Commun 2002 0.86
58 Proteomic analysis of anaplastic lymphoma cell lines: identification of potential tumour markers. Proteomics 2006 0.86
59 Upregulation of the CDC25A phosphatase down-stream of the NPM/ALK oncogene participates to anaplastic large cell lymphoma enhanced proliferation. Cell Cycle 2009 0.85
60 Non-antisense cellular responses to oligonucleotides. FEBS Lett 2002 0.84
61 Phosphoinositide signaling pathways: promising role as builders of epithelial cell polarity. Int Rev Cell Mol Biol 2009 0.84
62 A critical role of lipid rafts in the organization of a key FcgammaRIIa-mediated signaling pathway in human platelets. Thromb Haemost 2003 0.84
63 Chronic estradiol treatment reduces platelet responses and protects mice from thromboembolism through the hematopoietic estrogen receptor α. Blood 2012 0.83
64 The grape-derived polyphenol resveratrol differentially affects epidermal and platelet-derived growth factor signaling in human liver myofibroblasts. Int J Biochem Cell Biol 2005 0.83
65 The nucleophosmin-anaplastic lymphoma kinase oncogene interacts, activates, and uses the kinase PIKfyve to increase invasiveness. J Biol Chem 2011 0.83
66 Physiologic and pathologic changes of platelets in pregnancy. Platelets 2010 0.82
67 A central role of GPIb-IX in the procoagulant function of platelets that is independent of the 45-kDa GPIbalpha N-terminal extracellular domain. Blood 2010 0.82
68 The tyrosine phosphatase 1B regulates linker for activation of T-cell phosphorylation and platelet aggregation upon FcgammaRIIa cross-linking. J Biol Chem 2003 0.82
69 Polymorphisms of protein tyrosine phosphatase CD148 influence FcγRIIA-dependent platelet activation and the risk of heparin-induced thrombocytopenia. Blood 2012 0.81
70 Different roles of SHIP1 according to the cell context: the example of blood platelets. Adv Enzyme Regul 2007 0.80
71 Essential thrombocythemia and pregnancy. Eur J Obstet Gynecol Reprod Biol 2011 0.80
72 Phosphatidylinositol 3,4,5-trisphosphate modulation in SHIP2-deficient mouse embryonic fibroblasts. FEBS J 2005 0.80
73 Evidence for a positive role of PtdIns5P in T-cell signal transduction pathways. FEBS Lett 2010 0.79
74 A novel mass assay to quantify the bioactive lipid PtdIns3P in various biological samples. Biochem J 2012 0.79
75 [The PI3K/Akt/mTOR pathway: a new therapeutic target in the treatment of acute myeloid leukemia]. Bull Cancer 2006 0.79
76 cdc-like/dual-specificity tyrosine phosphorylation-regulated kinases inhibitor leucettine L41 induces mTOR-dependent autophagy: implication for Alzheimer's disease. Mol Pharmacol 2013 0.78
77 Cell adhesion regulates CDC25A expression and proliferation in acute myeloid leukemia. Cancer Res 2006 0.78
78 Structure-function relationship of estrogen receptors in cardiovascular pathophysiological models. Thromb Res 2012 0.78
79 Inherited platelet disorders and oral health. J Oral Pathol Med 2012 0.77
80 Platelet activation and arterial peripheral serotonin turnover in cardiac remodeling associated to aortic stenosis. Am J Hematol 2015 0.77
81 Class I phosphoinositide 3-kinases in normal and pathologic hematopoietic cells. Curr Top Microbiol Immunol 2012 0.77
82 Detection of myotubularin phosphatases activity on phosphoinositides in vitro and ex vivo. Methods Mol Biol 2009 0.76
83 The class I phosphoinositide 3-kinases α and β control antiphospholipid antibodies-induced platelet activation. Thromb Haemost 2016 0.75